Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. They invest in novel science and innovative approaches to bring promising drug candidates to patients and accelerate their progress by actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. Droia has an in-house team of experts and drug development professionals who follow the portfolio companies closely and provide hands-on support. Droia invests in early financing rounds and incubates new companies.

Venture Capital

Droia Ventures

Droia Ventures' headquarters in Meise, Belgium

Janwillem Naesens

Mathias Declercq

Sophie Bernier

Alexander Depauw

Guy Eelen

Kris Nys

Matthias Van Woensel

Sara Morren

Evelien Verdrengh

George Golumbeski

Matthias De Witte

Sebastian Bernales

Luc Dochez

Dan Nomura

Luc Verelst

Jo Bury

Sergio Quezada

Matthew Vander Heiden

Ludo Van Den Bosch

Eric Rowinsky

Roderick Beijersbergen

Diether Lambrechts

Description

People

Jobs